Background: The goals of the study were to: (1) evaluate trends in preoperative and prolonged postoperative narcotic use in carpal tunnel release (CTR); (2) characterize risks for prolonged narcotic use; and (3) evaluate narcotic use as an independent risk factor for complications following CTR. Methods: A query of a large insurance database from 2007-2016 was conducted. Patients undergoing open or endoscopic CTR were included. Revision surgeries or patients undergoing median nerve repair at the forearm, upper extremity fasciotomies, or with distal radius fractures were excluded. Preoperative use was defined as narcotic use between 1 to 4 months prior to CTR. A narcotic prescription between 1 and 4 months after surgery was considered prolonged postoperative use. Demographics, comorbidities, and other risk factors for prolonged postoperative use were assessed using a regression analysis. Subgroup analysis was performed according to the number of preoperative narcotic prescriptions. Narcotic use as a risk factor for complications, including chronic regional pain syndrome (CRPS) and revision CTR, was assessed. Results: In total, 66 077 patients were included. A decrease in prescribing of perioperative narcotics was noted. Risk factors for prolonged narcotic use included preoperative narcotic use, drug and substance use, lumbago, and depression. Preoperative narcotics were associated with increased emergency room visits, readmissions, CRPS, and infection. Prolonged postoperative narcotic use was linked to CRPS and revision surgery. Conclusions: Preoperative narcotic use is strongly associated with prolonged postoperative use. Both preoperative and prolonged postoperative prescriptions narcotic use correlated with increased risk of complications. Preoperative narcotic use is associated with a higher risk of postoperative CRPS.
Introduction
Carpal tunnel syndrome (CTS) is the most common neural compressive disorder of the upper extremity in the United States, affecting 5% of the working population, largely those involved in repetitive tasks with the hands, and 1% of the general population. 10 Consequently, surgical intervention for CTS remains one of the most frequently preformed operations of the hand and wrist, with estimates of 463 637 cases per year in the United States and over $1 billion dollars in health care costs. 14 To mitigate the pain of both the disease and surgical treatment, orthopedic surgeons commonly prescribe perioperative narcotic medications. The United States continues to be a leading prescriber of opioids compared with other countries, 23, 24, 28 yet these medications are not without risks and adverse side effects. 17, 21, 23, 37, 43, 44 The number of deaths from opioid overdoses have risen 2.8-fold from 2002 to 2015, and 2015 estimates cited an average of 42 deaths per day from overdoses in the United states alone. 6, 32 Opioid medications are still regarded as a cornerstone of postsurgical pain treatment, 34, 45 but the Centers for Disease Control and Prevention (CDC) has linked the use of narcotics for postsurgical pain as a gateway to long-term opioid dependence. 7, 11 Wunsch et al found that the percentage of patients filling narcotic prescriptions and the amount of medication given has increased over time. 46 It is an even more difficult task to transition those patients exposed to chronic narcotics to nonnarcotic pain regimens. 1, 8, 19 With the prevalence of carpal tunnel release (CTR) coupled with the deleterious effects of opioid-based postoperative pain regimens, it has become paramount for orthopedic surgeons to exercise caution when prescribing narcotics. 2, 3, 30, 31, 41 Despite these documented dangers, the long-term risks associated with chronic opioid use after surgery and the predisposing factors that result in prolonged use are not well documented in the literature with respect to CTR. 18 Therefore, the goals of the present study were to utilize a large national database to evaluate the following objectives to: (1) evaluate trends in preoperative and prolonged postoperative narcotic use in patients undergoing CTR; (2) characterize risk factors for prolonged narcotic use; and (3) evaluate narcotic use as an independent risk factor for complications following CTR.
Methods

Database
The PearlDiver database (www.pearldiverinc.com, Fort Wayne, Indiana) is a for-fee database that includes patient records from both private payer and Medicare insurance providers. The database contains patient demographics, prescription records, and numerous other data points for patients with Current Procedural Terminology (CPT) and International Classification of Diseases, Ninth Revision (ICD-9) and Tenth Revision (ICD-10) codes. All data are de-identified and, therefore, exempt from institutional review board approval.
For the present analysis, the Humana dataset within PearlDiver was utilized, as it contains prescription drug records, which are not included in a Medicare dataset. At the time of this analysis, the Humana dataset covered patients insured between the years 2007 and the fourth quarter of 2016.
Study Cohorts
The database was queried for patients who underwent either open or endoscopic CTR, using CPT codes 64721 and 29848, respectively, with a minimum follow-up of 6 months after the procedure. Patients with concomitant distal radius fractures requiring open reduction and internal fixation either concomitantly or prior to CTR, patients undergoing median nerve repair at the forearm (CPT 64834, 64835), hand or forearm fasciotomies (CPTs 24495, 25020, 25023, 25024, and 26037), and patients undergoing revision CTR were excluded from the analysis. After all inclusion and exclusion criteria were applied, 66 077 patients were included in the study.
The patient records were then queried for all prescription drug use to identify all possible formulation of narcotic prescriptions that were utilized during the study period. The following narcotics, including both brand name and generic formulations, were prescribed and included: oxycodone, oxycontin, hydrocodone, hydromorphone, morphine, fentanyl, oxymorphone, and propoxyphene. Prolonged postoperative narcotic use was defined as having at least one new narcotic prescription provided between 1 and 4 months after CTR. One month was the soonest available follow-up data point that the database allowed, and 4 months was chosen as an endpoint to avoid capturing patients who received a narcotic pain medication due to a subsequent surgery after their CTR and based on previous studies. 8 Patient demographics and medical comorbidities ( Table 1) were analyzed for all patients selected for this study and further stratified in the preoperative and prolonged postoperative narcotic groups. Demographics included patient age, gender, body mass index (BMI), tobacco use, and alcohol abuse. Substance use and abuse was defined solely according to the ICD-9 and ICD-10 codes used during the query, eg, the ICD-9 or ICD-10 code for methamphetamine is use/abuse whereas tobacco is only listed as use. Admittedly, each ICD code covers use and abuse but exact details were not known in the database. Medical comorbidities identified were diabetes mellitus, hyperlipidemia, hypertension, peripheral vascular disease, congestive heart failure, coronary artery disease, chronic kidney disease, chronic lung disease, chronic liver disease, depression, migraine disorder, back pain, and fibromyalgia.
Risk Factors for Prolonged Narcotic Use
Preoperative narcotic use was defined as having at least one narcotic prescription between 4 months and 1 month prior to the date of CTR. Subgroup analysis was also performed based on the number of narcotic prescriptions obtained from any provider during this time period and was broken down into 1 prescription, 2 prescriptions, 3 prescriptions, or 4 or more prescriptions. The month leading up to surgery was excluded to reduce the risk of capturing postoperative scripts that were given preoperatively as is commonly performed at our institution. Risk factors for prolonged postoperative use of narcotics after CTR other than preoperative narcotics were also evaluated including other preoperative medication prescriptions such as tramadol, anxiolytics (diazepam, clonazepam, temazepam, lorazepam, alprazolam, estazolam), muscle relaxants (cyclobenzaprine, baclofen, tizanidine), and methadone; pertinent patient demographics and comorbidities; and preoperative substance use or abuse such as tobacco, alcohol, marijuana use, cocaine, and amphetamine use. As previously mentioned, substance use was documented in the medical history of patients without precise details of severity or duration of use or abuse. The documentation of use or abuse was according to the ICD-9 and ICD-10 definitions, and the exact nature of substance use or abuse was not known within the database and may serve as a potential limitation.
Preoperative Narcotics as a Risk Factor for Postoperative Complications
The use of narcotics preoperatively was investigated as an independent risk factor for the following complications after CTR: emergency department visits within 30 days after surgery, hospital admission within 30 days after surgery, infection within 6 months after surgery (either irrigation and debridement for postoperative infection or a diagnosis of infection treated medically as defined by ICD-9 codes), chronic regional pain syndrome (CRPS) within 1 year postoperatively and revision ipsilateral CTR (either open or endoscopic) within the limits of database followup. Subgroup analysis was performed, and the use of narcotics preoperatively was further broken down into the number of prescriptions used.
Postoperative Narcotics as a Risk Factor for Postoperative Complications
The prolonged use of narcotics postoperatively was evaluated as an independent risk factor for the following complications after CTR: CRPS and revision CTR. These 2 outcomes were chosen as they are associated with negative outcomes in terms of patient satisfaction, functional recovery, rehabilitation, and additional costs to the patient as well associated with specific diagnoses within the database. They also served as the long-term complications, which occurred after 1 month from the index procedure to meet the study's definition for prolonged postoperative narcotic use as a risk factor.
Statistical Analysis
A multivariate logistic regression analysis was used to examine the independent effect of the variable of interest 
Results
Trends in Narcotic Use
Overall, 15 955 (24%) patients were found to have preoperative narcotic use and 18 595 (28%) patients had recorded prolonged postoperative use. From 2007 to 2016 there was a statistically significant decreasing trend in preoperative (P = .0007) or prolonged postoperative (P = .0121) narcotic use in patients undergoing CTR (Figure 1 ).
Risk Factors for Prolonged Postoperative Narcotic Use
Numerous statistically significant risk factors for prolonged narcotic use were identified ( Table 2 ). The most significant was preoperative narcotic use. The overall use of a narcotic prescription prior to surgery was a significant risk factor (odds ratio [OR]: 8.22, P < .0001), with increasing risk from 1 prescription (OR: 3.48, P < .0001) to 4 or more prescriptions (OR: 41.26, P < .0001). While the use of tramadol did carry a slightly elevated risk for prolonged narcotic use (OR: 1.09, P = .003), preoperative prescriptions for methadone (OR: 4.26, P < .0001), anxiolytics (OR: 1.49, P < .0001), and muscle relaxants (OR: 1.65, P < .0001) were associated with an increased risk of prolonged postoperative narcotic use.
Tobacco use (OR: 1.30, P < .0001) and cocaine use or abuse (OR: 1.63, P = .025) were risk factors for prolonged postoperative narcotic use, along with alcohol abuse (OR: 1.14 P = .014.), marijuana use or abuse (OR: 1.78 P < .0001). However, amphetamine use or abuse (P = .719) was not associated with any increased risk.
Several patient demographics and comorbidities were also associated with an increased risk of prolonged postoperative narcotic use. Age less than 50 years (OR: 1.36, P < .0001), obesity (OR: 1.07, P < .012), morbid obesity (OR: 1.33, P < .0001), depression (OR: 1.33, P < .0001), back pain or lumbago (OR: 1.41, P < .0001), migraine headaches (OR: 1.22, P < .0001), and fibromyalgia (OR: 1.21, P < .0001) all were associated with an increased risk. Of the relevant demographics and comorbidities we evaluated, male sex did not demonstrate an increased risk (P = .794).
Preoperative Narcotics as a Risk Factor for Postoperative Complications
The use of narcotics prior to CTR surgery was identified as a risk factor for several complications following surgery ( Table 3 ). The overall use of preoperative narcotics was a risk factor for emergency room visits within 30 days following CTR (OR: 1.35, P < .0001). The use of 4 or more narcotic prescriptions preoperatively yielded the greatest risk (OR: 1.54, P < .0001). The use of fewer narcotic prescriptions was also a risk factor but to a lesser degree (OR: 1.25-1.32). The overall use of preoperative narcotics was a risk factor for hospital admission within 30 days following CTR (OR: 1.33, P = .000). Four or more narcotic prescriptions preoperatively carried the greatest risk (OR: 1.59, P = .000). Increasing numbers of preoperative narcotic prescriptions demonstrated an increasing OR (1.12-1.29).
With regard to the occurrence of CRPS, overall use of preoperative narcotics correlated with an increased likelihood (1.69, P < .0001). Four or more narcotic prescriptions also had the highest risk (OR: 2.57, P < .0001) with an increasing trend with a higher number of preoperative prescriptions (OR: 0.99-2.57)
The overall use of narcotics prior to surgery (OR: 1.46, P = .000) and the use of 3 and 4 or more prescriptions (OR: 1.89, P = .000, OR: 1.75, P = .001, respectively) were risk factors for infection within 6 months of CTR arthroscopy. Preoperative narcotic prescriptions were not found to correlate with the incidence of revision CTR.
Postoperative Narcotics as a Risk Factor for Postoperative Complications
The prolonged use of narcotics postoperatively was also identified as a risk factor for complications following CTR (Table 4 ). Prolonged postoperative narcotic use after CTR was associated with an increased risk of CRPS (OR: 2.76, P < .0001) and an increased risk of revision CTR (OR: 1.61, P < .0001) when compared with patients who had not been prescribed narcotics beyond 3 months after surgery.
Discussion
The results of this study provide new insight into trends in narcotic use, risk factors that may predict the propensity for chronic opioid use in patients undergoing CTR, as well as adding to the growing body of knowledge that patients requiring both preoperative and prolonged postoperative narcotic may have an increased likelihood of adverse events and complications. Preventing the risk of narcotic misuse necessitates this knowledge of predisposing factors in certain populations as well as the develop of new treatment plans to mitigate pain while transitioning away from opioids. The important findings of the study were demonstrating a trend in decreasing preoperative and prolonged postoperative narcotic use. Preoperative use is a significant risk factor for a number of postoperative complications, including emergency department visits, admission to the hospital, infection, and CRPS. Preoperative narcotic use is also a risk factor for prolonged postoperative narcotic use in a dose dependent manner. Last, prolonged postoperative use is associated with an increased risk of revision CTR and CRPS.
A reexamination of the current trends in opioid prescribing among CTR procedures revealed a small, although statistically significant interval decrease from the years 2007 to 2016. As of 2015, surgery remains one of the frequent suppliers of opioid prescriptions ranked by specialty, with pain specialists and physical medicine and rehab at the forefront. 26 Acknowledging the guidelines of the CDC for the role of opioids in medical practice, surgeons are at the forefront of the efforts to reduce narcotic utilization as the medication remains a staple in the treatment of acute postoperative pain. 11, 38, 42 In the study cohort, approximately 15 955 out of the 66 007 patients (24%) demonstrated continued narcotic dependency for pain relief postoperatively. Many patients received more than one prescription either preoperatively or postoperatively. Risk factors associated with prolonged postoperative use included narcotic prescriptions and other adjuvants to pain regimens preoperatively (anxiolytics, muscles relaxants, methadone), use of certain substances such as tobacco, age less than 50 years, obesity, morbid obesity, back pain, migraines, fibromyalgia, and depression. Male sex and methamphetamine use were not associated with an increased risk. Interestingly, tobacco use was associated with a higher likelihood of prolonged postoperative narcotic use in the study's population. However, Zhang et al purported an association with nicotine use and a gene responsible for µ-opioid receptor exists which offers an explanation for the connection between nicotine use and postoperative narcotic dependence. 47 The symptoms of CTS share overlap with other disease entities including osteoarthritis and radiculopathy, and patient complaints are not always specific upon initial presentation. Oftentimes, patients with CTS undergo workup by a variety of primary care and subspecialties. Those with chronic pain may be prescribed narcotics for other medical conditions or prior to a definitive diagnosis of CTS, which account for the use of narcotics preoperatively. We also observed that preoperative use of narcotics was associated with substantial increases in some perioperative complications. The incidence of emergency room visits and readmissions is concerning, even more so when coupled with bundled reimbursements. Compelling evidence for a larger risk of infection was also present. Again, we observed that CRPS was positively correlated with preoperative narcotic prescriptions, precluding an optimal functional recovery from an ambulatory procedure. Overarching each complication category were trends that increased with the number of preoperative narcotics. Naturally, there may be confounding factors present that lead to this link, but our report is one of the initial studies establishing a link between complications and outpatient CTR procedures among both opioid naive and opioid tolerant patients. Furthermore, all of the study procedures were on an elective basis and were primary surgeries, removing the additional factors of trauma patients with oftentimes multiple injuries. Although prior authors have looked at risk factors for postoperative narcotic dependency, our study provides novel information on the heightened occurrence of complications, namely, CRPS and revision surgery in those with prolonged postoperative narcotic use. The added costs, lengthy recuperation, and mental toll on patients with revision surgery and CRPS, a devastating complication for hand surgery patients, 27 also help to reinforce the need to closely examine the aforementioned risk factors in primary CTR.
The exact etiology of CRPS remains unknown and involves complex interplay between the peripheral and central nervous systems that control nociception. Recent literature suggests an alteration in opioidergic neurotransmission in patients with CRPS which may explain the link between prolonged exposure to exogenous opioids and CRPS in the study cohort. 22, 35, 40 Evidence exists that narcotic medications also have immunomodulatory effects that potentially predispose patients to infection. 5, 12, 29 Furthermore, growing research in the orthopedic literature has correlated revision surgery with increased opioid use. 4, 20 One explanation is that increased perception of pain postoperatively may lead to negatively affect a patient's rehabilitation and ultimately the functional results. Given the increased risk of complications, surgeons should identify patients at risk of prolonged narcotic use, endeavor to limit narcotic use both pre-and postoperatively to no more than 2 prescriptions, and counsel patients on the risks of long-term opioid dependence on outcomes.
The present study had several limitations. Although other studies have evaluated opioid use in surgical patients, there is no consensus on the definition of prolonged postoperative narcotic use. 1, 6 The number of prescriptions supplied neither reflect the number of prescriptions filled nor the number of pills actually taken by the patient. Patients may also have been prescribed narcotic medications for other reasons aside from CTS including preexisting osteoarthritis, radiculopathy, or other chronic pain conditions. Moreover, while the database provided the timing of prescriptions at time increments of 1 month, it did not detail the number of pills nor the indication for the prescriptions which is another limitation of a database study. Patient adherence to narcotic pain prescriptions cannot be guaranteed, and pills may have obtained from other sources besides the surgeon. Given the retrospective nature of this study and the use of logistical regression, there is always a possibility that some confounding factor was not appropriately controlled. Certainly, correlation does not translate to direct causation. There is a possibility that patients undergoing CTR and getting CRPS was a route to access narcotics, ie, these complications are a risk factor for prolonged use rather than prolonged narcotic use being a risk factor for these long-term complications. The data in this study are also limited to the information supplied on the database, and documentation from initial procedures or follow-up encounters may be incomplete. Although concomitant distal radius fractures were not included in the database search, it did not identify patients with CTS secondary to history of remote trauma. Emergency room visits and readmissions were not limited to complications from surgery and as such may overestimate occurrences in the study population. The database did not exclude patients also undergoing multiple procedures, eg, trigger finger release and CTR, which may result in increased postoperative pain and narcotic use. Our study coincides with the existing literature on the subject of opioid prescribing in that it remains a common practice in the American population. 9, 16, 18, 25, 33, 39, 43, 45 Over prescription of narcotic analgesia remains common after CTR with the average patient needing only 10 tablets. 36 Various authors have look at methods of reducing the need for postoperative analgesia including limiting the number of pills, prescriber and patient education, as well as multimodal pain regimens. 13, 15, 41 The heighten occurrence of complications in the present study adds to the clinical guidelines of limiting narcotic use.
Conclusion
Although surgeons are under increasing pressure to maximize patient satisfaction and functional recovery while avoiding postoperative complications, the study adds to the growing body of evidence that surgeons should minimize narcotic prescriptions prior to and after CTS. Specific patient risk factors are associated with prolonged postoperative use and should be identified prior to an intervention. Both preoperative and postoperative narcotic use have been associated with postoperative complications. Preoperative narcotic use is associated with an increased risk of postoperative CRPS, and prolonged postoperative narcotic use was linked with CRPS as well as revision surgery. Future studies should be directed at better characterizing the risks of narcotics, better understanding the differences between patients who require a prolonged course of narcotics postoperatively as opposed to those whom discontinue opioids shortly after surgery, optimizing nonnarcotic analgesia such as nonsteroidal antiinflammatory drugs to minimize if not eliminate opioids, and improving the concordance of entire care teams including surgeons, primary care physicians, and pain specialists.
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